Vaxart Inc
VXRT0.320USD
-0.107-25.06%
交易中 （美東）報價延遲15分鐘
73.03M總市值
虧損本益比TTM
關於 Vaxart Inc 公司
Vaxart, Inc. 是一家臨牀階段的生物技術公司，主要專注於基於其載體佐劑抗原標準化技術 (VAAST) 專有口服疫苗平臺開發口服重組疫苗。其疫苗設計爲使用藥丸給藥，可在無需冷藏的情況下儲存和運輸，並消除針刺傷的風險。其開發計劃包括旨在預防諾如病毒（急性胃腸炎的病因）、冠狀病毒（包括 SARS-CoV-2 (COVID-19)）和流感的藥丸疫苗。此外，該公司還爲其針對宮頸癌和人乳頭瘤病毒引起的發育不良的治療性疫苗候選物生成了臨牀前數據。該公司的平臺技術採用基於載體的方法，由各種組件組成，例如載體（腺病毒 5 型 (Ad5)；抗原 (Ad5 DNA)；佐劑（Toll 樣受體 3 (TLR3)）和其專有的腸溶片。
公司簡介
公司代碼VXRT
公司名稱Vaxart Inc
上市日期Mar 17, 1980
CEOMr. Steven (Steve) Lo
員工數量105
證券類型Ordinary Share
年結日Mar 17
公司地址170 Harbor Way, Suite 300
城市SOUTH SAN FRANCISCO
上市交易所US 'Other OTC' and Grey Market
國家United States of America
郵編94080
電話16505503500
網址https://vaxart.com/
公司代碼VXRT
上市日期Mar 17, 1980
CEOMr. Steven (Steve) Lo
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Edward B. Berg
Mr. Edward B. Berg
Senior Vice President, General Counsel
Senior Vice President, General Counsel
435.74K
+1053.17%
Mr. Jeroen Grasman
Mr. Jeroen Grasman
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
350.00K
--
Dr. Elaine J. Heron, Ph.D.
Dr. Elaine J. Heron, Ph.D.
Independent Director
Independent Director
51.65K
+44.88%
Mr. Steven (Steve) Lo
Mr. Steven (Steve) Lo
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.14K
-97.54%
Dr. Sean N. Tucker, Ph.D.
Dr. Sean N. Tucker, Ph.D.
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Mr. W. Mark Watson
Mr. W. Mark Watson
Independent Director
Independent Director
--
--
Dr. James F. Cummings, M.D.
Dr. James F. Cummings, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Matt Stein
Matt Stein
IR Contact Officer
IR Contact Officer
--
--
Mr. Kevin P. Finney
Mr. Kevin P. Finney
Independent Director
Independent Director
--
--
Ms. Laurie Hastings
Ms. Laurie Hastings
Senior Vice President of Human Resources
Senior Vice President of Human Resources
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Edward B. Berg
Mr. Edward B. Berg
Senior Vice President, General Counsel
Senior Vice President, General Counsel
435.74K
+1053.17%
Mr. Jeroen Grasman
Mr. Jeroen Grasman
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
350.00K
--
Dr. Elaine J. Heron, Ph.D.
Dr. Elaine J. Heron, Ph.D.
Independent Director
Independent Director
51.65K
+44.88%
Mr. Steven (Steve) Lo
Mr. Steven (Steve) Lo
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.14K
-97.54%
Dr. Sean N. Tucker, Ph.D.
Dr. Sean N. Tucker, Ph.D.
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Mr. W. Mark Watson
Mr. W. Mark Watson
Independent Director
Independent Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月23日 週五
更新時間: 5月23日 週五
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
4.54%
Sio Capital Management, LLC
2.45%
Geode Capital Management, L.L.C.
1.17%
BlackRock Institutional Trust Company, N.A.
0.78%
Millennium Management LLC
0.42%
Other
90.64%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
4.54%
Sio Capital Management, LLC
2.45%
Geode Capital Management, L.L.C.
1.17%
BlackRock Institutional Trust Company, N.A.
0.78%
Millennium Management LLC
0.42%
Other
90.64%
股東類型
持股股東
佔比
Investment Advisor
6.33%
Hedge Fund
3.23%
Investment Advisor/Hedge Fund
2.18%
Individual Investor
1.35%
Research Firm
0.26%
Pension Fund
0.05%
Bank and Trust
0.02%
Family Office
0.01%
Other
86.57%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
223
30.63M
13.42%
-33.98M
2025Q1
260
32.73M
14.34%
-33.64M
2024Q4
273
38.15M
16.82%
-29.38M
2024Q3
304
39.77M
17.54%
-31.47M
2024Q2
307
43.16M
19.03%
-9.14M
2024Q1
311
42.29M
24.34%
-1.37M
2023Q4
307
17.70M
11.60%
-12.17M
2023Q3
319
19.94M
13.09%
-20.38M
2023Q2
329
30.49M
20.10%
-12.31M
2023Q1
343
36.99M
27.31%
-14.55M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
10.37M
4.54%
+291.51K
+2.89%
Mar 31, 2025
Sio Capital Management, LLC
5.58M
2.45%
-5.93M
-51.51%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.66M
1.17%
+58.98K
+2.27%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.78M
0.78%
-9.61K
-0.54%
Mar 31, 2025
Millennium Management LLC
955.87K
0.42%
-2.03M
-68.04%
Mar 31, 2025
Squarepoint Capital LLP
804.48K
0.35%
+287.68K
+55.67%
Mar 31, 2025
State Street Global Advisors (US)
790.25K
0.35%
+101.40K
+14.72%
Mar 31, 2025
Finney Michael J
702.84K
0.31%
+16.00K
+2.33%
Jun 13, 2025
SilverArc Capital Management, LLC
683.83K
0.3%
-393.96K
-36.55%
Mar 31, 2025
Lee (Phillip E.)
631.62K
0.28%
+397.95K
+170.31%
Mar 24, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Invesco RAFI US 1500 Small-Mid ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
佔比0%
Invesco NASDAQ Future Gen 200 ETF
佔比0%
Fidelity Nasdaq Composite Index ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
